Latest filing published 08 Sept 2026 for Sarepta Therapeutics, Inc., €421k.
Insider track record
Cristin Rothfuss: trading record in brief
Cristin Rothfuss is a declared insider of Sarepta Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 26 November 2024 and 4 September 2026, the trades on record add up to 16 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 8 September 2026: a share grant of €421k, in Sarepta Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Cristin Rothfuss
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,025 shares@ US$22.220.024% mcap62.6% of flowCommon StockSEC:0001193125-26-385541:0
- 974 shares@ US$17.032.1% of flowCommon StockSEC:0001193125-26-106697:0
- 484 shares@ US$16.951.1% of flowCommon StockSEC:0001193125-26-102708:0
- 408 shares@ US$16.200.8% of flowCommon StockSEC:0001193125-26-089439:0
- 229 shares@ US$21.120.6% of flowCommon StockSEC:0001193125-25-305662:0
- 93,875 shares0Common StockSEC:0001193125-25-197422:0
- 491 shares@ US$100.136.7% of flowCommon StockSEC:0000950170-25-037527:0
- 1,131 shares@ US$103.7016.2% of flowCommon StockSEC:0000950170-25-036693:0
- 288 shares@ US$101.344.1% of flowCommon StockSEC:0000950170-25-035006:0
- 391 shares@ US$103.775.8% of flowCommon StockSEC:0000950170-25-032758:0
- 2,000 shares0Common StockSEC:0000950170-24-131938:0
11 of 11 declarations
